Cure My Disease

Don't miss your cure!

 Log in / Sign up

UK researchers track Real-World success of CLL drug acalabrutinib

NCT ID NCT05557695

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes about 350 people with chronic lymphocytic leukemia (CLL) who received the drug acalabrutinib through a UK early access program. Researchers will review medical records to see how long patients went without their cancer worsening and how long they lived. No new treatments are given; the goal is to learn how well acalabrutinib works in everyday practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia Leukemia, B-Cell

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Contacts and locations

Locations

  • Research Site

    RECRUITING

    Aylesbury, United Kingdom

  • Research Site

    RECRUITING

    Bath, United Kingdom

  • Research Site

    RECRUITING

    Birmingham, United Kingdom

  • Research Site

    RECRUITING

    Bournemouth, United Kingdom

  • Research Site

    RECRUITING

    Cardiff, United Kingdom

  • Research Site

    RECRUITING

    Cornwall, United Kingdom

  • Research Site

    RECRUITING

    Dartford, United Kingdom

  • Research Site

    RECRUITING

    Derby, United Kingdom

  • Research Site

    RECRUITING

    Doncaster, United Kingdom

  • Research Site

    RECRUITING

    Dorset, United Kingdom

  • Research Site

    RECRUITING

    Eastbourne, United Kingdom

  • Research Site

    RECRUITING

    Hull, United Kingdom

  • Research Site

    RECRUITING

    Leicester, United Kingdom

  • Research Site

    RECRUITING

    Lincoln, United Kingdom

  • Research Site

    RECRUITING

    Liverpool, United Kingdom

  • Research Site

    RECRUITING

    London, SE1 9RT, United Kingdom

  • Research Site

    RECRUITING

    London, W12 OHS, United Kingdom

  • Research Site

    RECRUITING

    Mid Yorkshire, United Kingdom

  • Research Site

    RECRUITING

    Middlesbrough, United Kingdom

  • Research Site

    RECRUITING

    Newcastle, United Kingdom

  • Research Site

    RECRUITING

    North Shields, United Kingdom

  • Research Site

    RECRUITING

    Norwich, United Kingdom

  • Research Site

    RECRUITING

    Nottingham, United Kingdom

  • Research Site

    RECRUITING

    Oxford, United Kingdom

  • Research Site

    RECRUITING

    Plymouth, United Kingdom

  • Research Site

    RECRUITING

    Southampton, United Kingdom

  • Research Site

    RECRUITING

    Stockton-on-Tees, United Kingdom

  • Research Site

    RECRUITING

    Stoke-on-Trent, United Kingdom

  • Research Site

    RECRUITING

    Wigan, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.